
Dopamine D2 receptor-mediated modulation of adenosine A2A receptor agonist binding within the A2AR/D2R oligomer framework
Keywords: A2AR; D2R; Parkinson’s disease; Receptor–receptor allosterism; Antiparkinsonian drugs